- AMAG Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing
Amag Pharmaceuticals (AMAG) 8-KCurrent report
Filed: 20 Apr 04, 12:00am
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 20, 2004 (April 16, 2004)
ADVANCED MAGNETICS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
| Commission File No. 0-14732 |
| 04-2742593 |
(State or other jurisdiction |
|
|
| (I.R.S. Employer |
|
|
|
|
|
61 Mooney Street |
| 02138 | ||
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (617) 497-2070
Item 12. Results of Operations and Financial Condition.
The following information, including the Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
On April 16, 2004, Advanced Magnetics, Inc. announced its financial results for the second fiscal quarter of 2004 ended March 31, 2004. A copy of the press release is attached hereto as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADVANCED MAGNETICS, INC. | ||
|
| ||
|
| ||
| By: | /s/ James A. Matheson |
|
| Name: James A. Matheson | ||
| Title: Vice President of Finance | ||
|
| ||
|
| ||
Dated: April 20, 2004 |
|
3
EXHIBIT INDEX
Exhibit Number |
| Description |
|
|
|
99.1 |
| Press Release dated April 16, 2004 |
4